PREMOD: Peripheral Vascular REactivity and Muscular Oxygenation in Diabetes Mellitus

Sponsor
University Ghent (Other)
Overall Status
Recruiting
CT.gov ID
NCT04226820
Collaborator
University Hospital, Ghent (Other)
125
1
1
57
2.2

Study Details

Study Description

Brief Summary

Oxygen is required for an optimal muscle function. In patients with diabetes mellitus, hyperglycemia can cause vascular complications. The endothelium (inter layer of the blood vessels) can be damaged leading to a reduced oxygen flow towards the muscle cells. Besides, it is possible that mitochondrial dysfunction is occuring leading to reduced extraction of oxygen.

Both conditions will lead to a reduced flow of oxygen towards the muscle and this can have impact on the production of energy necessary for optimal functioning.

In this study, the investigators will examine the functionality of the blood vessels (1) and the uptake of oxygen into the muscles (2) in patients with diabetes mellitus type 1 and type 2 (with and without vascular complications) compared to healthy persons.

Condition or Disease Intervention/Treatment Phase
  • Other: examination: blood pressure assessment
  • Other: examination: Flow Mediated Dilatation (FMD)-test
  • Other: examination: handgrip exercise test with Near infrared spectroscopy (NIRS)-monitoring
  • Other: examination: measurement of glucose by a finger prick
N/A

Detailed Description

The investigators plan to recruit in total 125 participants who will be divided into 3 main groups: (I) diabetes mellitus type 1 (with (a) or without (b) vascular complications), (II) diabetes mellitus type 2 (with (a) or without (b) vascular complications), and (III) healthy persons. Diabetes mellitus will be defined by the guidelines of the American Diabetes Association (ADA).

The examinations for this study consist of a blood pressure assessment, Flow Mediated Dilatation (FMD)-measurement, and a handgrip exercise test. The protocol will take approximately 2 hours.

The investigator who performs the FMD-test followed a course and passed thorough evaluation.

The blood pressure assessment will be continuously for 20 minutes to avoid large bias.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
125 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Participants are divided into 3 groups based on their diagnosis: diabetes mellitus type 1, diabetes mellitus type 2, and healthy persons. Each participant (independent of group) will have the same examinations. There is no retesting of the same participant in other conditions.Participants are divided into 3 groups based on their diagnosis: diabetes mellitus type 1, diabetes mellitus type 2, and healthy persons. Each participant (independent of group) will have the same examinations. There is no retesting of the same participant in other conditions.
Masking:
None (Open Label)
Masking Description:
There is no masking because the participant knows his diagnosis. Besides, the investigator checks the blood sugar at different times during the examinations, so also the investigator is not blinded. In this study, blinding would have no additional value.
Primary Purpose:
Other
Official Title:
Peripheral Vascular REactivity and Muscular Oxygenation in Diabetes Mellitus
Actual Study Start Date :
Feb 1, 2020
Anticipated Primary Completion Date :
Oct 31, 2024
Anticipated Study Completion Date :
Oct 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: participant

Participants are divided into 3 groups based on their diagnosis: diabetes mellitus type 1, diabetes mellitus type 2, and healthy persons. Each participant (independent of group) will have the same examinations. There is no retesting of the same participant in other conditions.

Other: examination: blood pressure assessment
blood pressure measurement for 30 minutes, dominant side

Other: examination: Flow Mediated Dilatation (FMD)-test
Flow Mediated Dilatation (FMD)-test for measuring the endothelial functionality

Other: examination: handgrip exercise test with Near infrared spectroscopy (NIRS)-monitoring
participant does a maximal exercise test by a handgrip strength test with simultaneously monitoring of the muscular oxygenation

Other: examination: measurement of glucose by a finger prick
follow-up of blood sugar (glucose) during examinations by a finger prick

Outcome Measures

Primary Outcome Measures

  1. Flow Mediated Dilatation (FMD)-test [20 minutes, at study-day (participants have to come only once, no follow-up, no re-testing)]

    flow mediated dilatation test

  2. Near-infrared spectroscopy during exercise [30 minutes, at study-day (participants have to come only once, no follow-up, no re-testing)]

    analysis of changes in oxygenated blood during exercise

  3. exercise test wilt hand held dynamometer [30 minutes, at study-day (participants have to come only once, no follow-up, no re-testing)]

    analysis of strength and exercise capacity

Secondary Outcome Measures

  1. Blood pressure analysis [20 minutes, at study-day (participants have to come only once, no follow-up, no re-testing)]

    measurement of basal blood pressure (systolic and diastolic)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • men and women

  • age 18-85 years old

  • diabetes mellitus type 1 or type 2 (with or without vascular complications, healthy participants

Exclusion Criteria:
  • other types of diabetes mellitus than type 1 or type 2

  • alcohol abuse

  • active cancer

  • pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Gent, Rehabilitation Sciences Ghent Oost-Vlaanderen Belgium 9000

Sponsors and Collaborators

  • University Ghent
  • University Hospital, Ghent

Investigators

  • Principal Investigator: Samyah Shadid, Prof. dr., University hospital of Ghent and University of Ghent

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Ghent
ClinicalTrials.gov Identifier:
NCT04226820
Other Study ID Numbers:
  • B670201940995
First Posted:
Jan 13, 2020
Last Update Posted:
Nov 26, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Ghent
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 26, 2021